An investigation into the potential applicability of gel dosimeters for dosimetry in boron neutron capture therapy

Authors

  • F. Rahmani University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran
  • H Khalafi Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran
  • S.M. Abtahi University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran
  • S.M.R. Aghamiri University of Shahid Beheshti, Radiation Medicine Department, P. O. Box 19839- 63113, Tehran, Iran
Abstract:

Background: The aim of this work was to establish how well gel dosimeters performed, as substitutes for brain tissue compared with standard phantom materials such as water, polymethyl-methacrylate (or PMMA), A150 plastic and TE- liquid phantom material for dosimetry of neutron beams in boron neutron capture therapy. Materials and Methods: Thermal neutron fluence, photon dose and epithermal neutron dose distributions were computed for the epithermal neutron beam of the optimized linac based BNCT. Results: Amongst all investigated phantom materials, TE-liquid was shown to be a better substitute for brain tissue than other phantom materials. The differences between TE- liquid and brain at the depth of 6.1 cm for thermal neutron fluence, gamma dose and epithermal neutron dose distributions was calculated 2.80%, 2.40% and -13.87% , respectively. In comparison with the other gel dosimeters, LMD2 provided a better simulation of radiation transport in the brain. It's results differed from the real brain, at the depth of 6.1 cm, for thermal neutron fluence, gamma dose and epithermal neutron dose distributions, by -1.27%, 4.20% and 21.05% respectively. Conclusion: Even though, in gamma dose distribution the LMD2 has large deviation from brain tissue distribution, the deviation is approximately independent of depth, so the results can be multiplied by a constant coefficient to be more consistent with reality. Even though, TE- liquid showed satisfactory results for brain tissue substitution in BNCT, but some properties of gel dosimeters such as three dimensionality, make LMD2 a potentially good dosimeter for dosimetric verification in BNCT.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

an investigation into the potential applicability of gel dosimeters for dosimetry in boron neutron capture therapy

background: the aim of this work was to establish how well gel dosimeters performed, as substitutes for brain tissue compared with standard phantom materials such as water, polymethyl-methacrylate (or pmma), a150 plastic and te- liquid phantom material for dosimetry of neutron beams in boron neutron capture therapy. materials and methods: thermal neutron fluence, photon dose and epithermal neut...

full text

Investigation the potential of Boron neutron capture therapy (BNCT) to treat the lung cancer

Introduction: Boron neutron capture therapy (BNCT) is recommended to treat the glioblastoma tumor. It is well known that neuron beams are more effective treatment than photon beams to treat hypoxia tumors due to interaction of neutron with nucleus and production of heavy particles such as 7Li and alpha particle. In this study to evaluate the suitability of BNCT for treating of ...

full text

The Dosimetry Calculation for Boron Neutron Capture Therapy

BNCT incorporates the targeting principles of chemotherapy and the anatomical localization principles of conventional radiotherapy but with three distinct advantages:  Current boron compounds at the required concentrations are non-toxic.  The time interval between drug administration and neutron irradiation can be chosen to maximize the concentration differential between tumour and normal tis...

full text

Boron Neutron Capture Therapy

A project aimed at the development of an accelerator facility devoted to Boron Neutron Capture Therapy (BNCT) is ongoing at the National Atomic Energy Commission of Argentina [1]. In a first stage of development, the accelerator will be capable of delivering proton or deuteron beams of 30 mA at about 1.4 MeV which is suitable for neutron production through the 9Be(d,n) reaction. In this context...

full text

Finnish dosimetric practice for epithermal neutron beam dosimetry in boron neutron capture therapy

Boron neutron capture therapy (BNCT) is a form of chemically targeted radiotherapy that utilises the high neutron capture cross-section of boron-10 isotope to achieve a preferential dose increase in the tumour. The BNCT dosimetry poses a special challenge as the radiation dose absorbed by the irradiated tissues consists of several dose components with different relative biological effectiveness...

full text

A Monte Carlo study of SPECT in boron neutron capture therapy for a heterogeneous human phantom

Background: Boron neutron capture therapy (BNCT) is a binary radiotherapy combining biochemical targeting with neutron irradiation. However, monitoring the boron distribution is a fundamental problem in BNCT. Prompt gamma rays emitted by boron capture reaction can be used to address the issue. Materials and Methods: The general-purpose Monte Carlo toolkits Geant4 and MCNP were used for the simu...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 12  issue None

pages  139- 149

publication date 2014-04

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023